Chronic olanzapine, serotonin receptors, and subsequent serotonin toxicity

Journal of Clinical Psychopharmacology

Volumn 30, Issue 5, 2010, Pages 628-629

  Monte, Andrew A ^a,b   Waksman, Javier C ^a,b,c  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLORAZEPATE; COTRIMOXAZOLE; CYPROHEPTADINE; FLUOXETINE; INSULIN GLARGINE; INSULIN LISPRO; LORAZEPAM; METAXALONE; OLANZAPINE; PROPOFOL; ROCURONIUM; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; TRAMADOL; ZOLPIDEM;

ADD ON THERAPY; ADULT; ALCOHOLISM; BEDTIME DOSAGE; BIPOLAR DISORDER; CASE REPORT; CHRONIC DISEASE; CHRONIC PAIN; CLONUS; DELIRIUM; DEPRESSION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HUMAN; HYPERREFLEXIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE UNIT; INTUBATION; LETTER; LONG TERM CARE; MENTAL DISEASE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REPEATED DRUG DOSE; SEROTONIN SYNDROME; TACHYCARDIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREMOR; URINARY TRACT INFECTION;

BENZODIAZEPINES; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, SEROTONIN; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 77957274258     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181ef09f8     Document Type: Letter

References (14)

1. Haslett C, Kumar S. Can olanzapine be implicated in causing serotonin syndrome? Psychiatry Clin Neurosci. 2002;56: 533-535.
2. Karki S, Masood G. Combination risperidone and SSRI-induced sertotonin syndrome. Ann Pharmacother. 2003;37: 388-391. (Pubitemid 36249640)
3. Hamilton S, Malone K. Serotonin syndrome during treatment with paroxetine and risperidone. J Clin Psychopharmacol. 2000;20: 103-105. (Pubitemid 30056364)
4. Isbister G, Downes F, Whyte I. Olanzapine and serotonin toxicity. Psychiatry Clin Neurosci. 2003;57: 241-242.
5. Boddy R, Ali R, Dowsett R. Use of sublingual olanzapine in serotonin syndrome [abstract]. J Toxicol Clin Toxicol. 2004; 42: 725.
6. Dunkley EJ, Isbister GK, Sibbritt D, et al. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. Q J Med. 2003;96: 635-642. (Pubitemid 37063272)
7. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352: 1112-1120.
8. Nisijima K, Yoshino T, Ishiguro T. Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology. 1999;150: 9-14. (Pubitemid 30350808)
9. Girgenti MJ, Nisenbaum LK, Bymaster F, et al. Antipsychotic-induced gene regulation in multiple brain regions. J Neurochem. 2010;113: 175-187.
10. Tarazi F, Zhang K, Baldessarini R. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A, and 2C receptors in rat forebrain regions. Psychopharmacology. 2002;161: 263-270. (Pubitemid 34591664)
11. Feher LZ, Kalman J, Puskas LG, et al. Impact of haloperidol and risperidone on gene expression profile in the rat cortex. Neurochem Int. 2005;47: 271-280. (Pubitemid 40943469)
12. Councill J, Tucker E, Haskell G, et al. Limited influence of olanzapine on adult forebrain neural precursors in vitro. Neurosc. 2006;140: 111-122.
13. Baldessarini R. Drug therapy of depression and anxiety disorders. In: Brunton L, Lazo J, Parker K, eds. Goodman and Gilman sVThe Pharmacological Basis of Therapeutics. New York: McGraw-Hill Companies; 2006: 437.
14. Bolden-Watson C, Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 1993;52: 1023-1029. (Pubitemid 23057151)